Prehospital care in acute coronary syndrome;Die präklinische versorgung des akuten koronarsyndroms

Internist

Volumn 43, Issue SUPPL. 1, 2002, Pages

  Arntz, Hans Richard ^a   Schultheiss, H P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TENECTEPLASE;

ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DRUG EFFICACY; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HOSPITAL CARE; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; ST SEGMENT;

ASPIRIN; CLINICAL TRIALS; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; HEPARIN; HUMANS; MYOCARDIAL INFARCTION; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 0036556198     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-002-0563-3     Document Type: Conference Paper

References (35)

1. American Heart Association/ILCOR (2000) Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care - An international consensus on science. Resuscitation 46: 1-448
2. Antman EM, Giugliano RP, Gibson CM et al. (1999) Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 99: 2720-2732
3. Arntz HR, Stern R, Linderer T, Schröder R (1992) Efficiency of a physician-operated mobile intensive care unit for prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 70: 417-420
4. Arntz HR, Tebbe U, Schuster HP, Sauer G, Meyer J (2000) Leitlinien zur Diagnostik und Therapie des akuten Herzinfarktes in der Prähospitalphase. Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung. Z Kardiol 89: 364-372
5. ASSENT-3 Study Group (2001) Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358: 605-613
6. Bailey ED, O'Connor RE, Ross RW (2000) The use of emergency medical dispatch protocols to reduce the number of inappropriate scene responses made by advanced life support personnel. Prehosp Emerg Care 4: 186-189
7. Boersma E, Maas ACP, Deckers JW, Simoons ML (1996) Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet 348: 771-775
8. Chan AW, Moliterno DJ (2001) Defining the role of abciximab for acute coronary syndromes: Lessons from CADILLAC, ADMIRAL, GUSTO IV, GUSTO V, and TARGET. Curr Opin Cardiol 16: 375-383
9. Collins R, MacMahon S, Flather M et al. (1996) Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: Systematic overview of randomised trials. BMJ 313: 652-659
10. Dracup K, Alonzo AA, Atkins JM et al. (1997) The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: Recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies to Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction. Ann Intern Med 126: 645-651
11. GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell 'Infarto Miocardio) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet I: 397-401
12. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T (1997) Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 337: 1648-1653
13. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17.187 cases of suspected acute myocardial infarction: ISIS-2. Lancet II: 349-360
14. Juliard JM, Himbert D, Cristofini P et al. (1999) A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty. Am J Cardiol 83: 305-310
15. Kudenchuk PJ, Maynard C, Cobb LA, Wirkus M, Martin JS, Kennedy JW, Weaver WD (1998) Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: The Myocardial Infarction Triage and Intervention (MITI) project. J Am Coll Cardiol 32: 17-27
16. Loubeyre C, Lefevre T, Louvard Y et al. (2001) Outcome after combined reperfusion therapy for acute myocardial infarction, combining prehospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J 22: 1128-1135
17. Löwel H, Engel S, Hörmann A, Gostomzyk J, Bolte HD, Keil U (2000) Akuter Herzinfarkt und plötzlicher Herztod aus epidemiologischer Sicht. Intensivmedizin 36: 652-661
18. Montalescot G, Barragan P, Wittenberg O et al. (2001) Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344: 1895-1903
19. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ (2000) Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA 283: 2686-2692
20. Rawles J (1994) Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 23: 1-5
21. Ross AM, Coyne KS, Reiner JS et al. (1999) A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol 34: 1954-1962
22. Schömig A, Kastrati A, Dirschinger J et al. (2000) Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 343: 385-391
23. Schreiber W, Pieper O, Herkner H, Laggner AN, Huber K (2000) "Inappropriate" thrombolysis in suspected myocardial infarction. Wien Klin Wochenschr 112: 912-916
24. Schröder K, Wegscheider K, Zeymer U, Tebbe U, Schröder R (2001) Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet 358: 1479-1486
25. Schuchert A, Hamm C, Scholz J, Klimmeck S, Goldmann B, Meinertz T (1999) Prehospital testing for troponin T in patients with suspected acute myocardial infarction. Am Heart J 138: 45-48
26. Simoons ML (2001) Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: The GUSTO IV-ACS randomised trial. Lancet 357: 1915-1924
27. The European Myocardial Infarction Project Group (1993) Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 329: 383-389
28. The GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329: 703-709
29. The SPEED Group (2000) Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. Circulation 101: 2788-2794
30. Topol EJ (2001) Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial. Lancet 357: 1905-1914
31. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG (2000) Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med 343: 1206-1209
32. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E (2000) Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 356: 9-16
33. Weaver WD, Simes RJ, Betriu A et al. (1997) Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review. JAMA 278: 2093-2098
34. Weaver WD, Cerqueira M, Halistom AP, Litwin PE, Martin JS, Kudenchuk PJ, Eisenberg M (1993) Prehospital-initiated vs. hospital-initiated thrombolytic therapy. The MITI trial. JAMA 270: 1211-1216
35. Young JJ, Kereiakes DJ, Grines CL (2000) Low-molecular-weight heparin therapy in percutaneous coronary intervention: The NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators. J Invasive Cardiol 12: E14-18